EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieVergleichsstudieOpen Access · CC BY 4.0

Age and Procedural Timing for Asymptomatic Severe Aortic Stenosis: Analysis From the EARLY TAVR Trial

Kashish Goel iD, Brian R Lindman iD, Allan Schwartz iD, David J Cohen iD, Gennaro Giustino, J Bradley Oldemeyer iD, Justin Strote, Vasilis Babaliaros iD, Chandan M Devireddy iD, Michael P Fischbein iD, William F Fearon iD, David Daniels und 25 weitere

Circulation: Cardiovascular Interventions · 2026-08 · 19 (8)

DOI: 10.1161/circinterventions.125.016370 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Circulation: Cardiovascular Interventions, 2026-08. Verfasst von Kashish Goel und 36 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Medicine (K.G., B.R.L.), Vanderbilt University Medical Center, Nashville, TN. Hauptthemen laut MEDLINE: Aortic Valve Stenosis, Transcatheter Aortic Valve Replacement, Aortic Valve. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The EARLY TAVR trial (Evaluation of TAVR Compared to Surveillance for Patients with Asymptomatic Severe Aortic Stenosis) demonstrated that early transcatheter aortic valve replacement (TAVR) was superior to clinical surveillance (CS) in asymptomatic severe aortic stenosis. The relative impact of early TAVR versus CS strategy by age is unknown. METHODS: The study population of the EARLY TAVR trial was stratified into 4 age groups: 65 to 69 years (n=141), 70 to 74 years (n=263), 75 to 79 years (n=250), and ≥80 years (n=247). Associations between age and the trial primary end point of death, stroke, or unplanned cardiovascular hospitalization; the composite end point of death, stroke, or heart failure hospitalization; and its individual components were examined. Interaction tests evaluated whether the treatment effect of early TAVR versus CS differed by age. RESULTS: No interaction was detected between age and the treatment effect of early TAVR versus CS for the composites or individual outcomes. We observed lower stroke rates with early TAVR compared with CS in the youngest (65–69 years, absolute risk reduction, 13%; P =0.008) and oldest (≥80 years; absolute risk reduction, 12.3%; P =0.029) age groups. The absolute difference in heart failure hospitalization rates between the early TAVR and CS arms at 2 years was greatest in the oldest patients (≥80 years, 9.1%; 75–79 years, 5.9%; 70–74 years, 5.1%; 65–69 years, 4.4%). In the CS group, time to conversion to AVR was similar across all age groups (median, 11 months; P =0.73). Approximately one-third of younger patients (65–69 years) in the CS arm presented with acute valve syndrome at the time of conversion, the frequency of which tended to increase with age ( P =0.06). CONCLUSIONS: In the EARLY TAVR trial, the relative benefit of early TAVR over CS was consistent among all age groups. The greatest absolute reduction in stroke rate with early TAVR compared with CS appeared in the youngest and oldest groups, whereas reduction in heart failure hospitalization was most pronounced in the oldest patients. These data suggest that early TAVR should be considered in all age groups above 65 years. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT03042104.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aortic Valve StenosisTranscatheter Aortic Valve ReplacementAortic ValveHumansFemaleMaleAged, 80 and overAgedTime FactorsAge FactorsTreatment OutcomeSeverity of Illness IndexRisk FactorsStrokeAsymptomatic DiseasesHeart FailureHospitalization

Stichwörter der Autor:innen

age groupsaortic valve stenosisasymptomatic diseasesstroketranscatheter aortic valve replacement

Autor:innen und Institutionen

  • Division of Cardiovascular Medicine (K.G., B.R.L.), Vanderbilt University Medical Center, Nashville, TN.
  • Structural Heart and Valve Center (B.R.L.), Vanderbilt University Medical Center, Nashville, TN.
  • Columbia University Medical Center/NewYork-Presbyterian Hospital (A.S., D.J.C., M.B.L.).
  • Cardiovascular Research Foundation, New York, NY (D.J.C., M.B.L.).
  • St. Francis Hospital and Heart Center, Roslyn, NY (D.J.C.).
  • Gagnon Cardiovascular Institute, Morristown Medical Center, NJ (G.G., P.G.).

ORCID-Profile: Kashish Goel, Brian R Lindman, Allan Schwartz, David J Cohen, J Bradley Oldemeyer, Vasilis Babaliaros, Chandan M Devireddy, Michael P Fischbein, William F Fearon, Adnan K Chhatriwalla, Hussam S Suradi, Pinak Shah, Molly Szerlip, Thom Dahle, Dimitrios Apostolou, Raj Makkar, Charles J Davidson, Paul Sorajja, James T DeVries, Jeffrey Southard, Jeremiah P Depta, Salem Badr, Mayra Guerrero, James M McCabe, Philippe Pibarot, Yizhuo Wang, Martin B Leon, Philippe Généreux

Zitieren

APA

Goel, K., Lindman, B. R., Schwartz, A., Cohen, D. J., Giustino, G., Oldemeyer, J. B., Strote, J., Babaliaros, V., Devireddy, C. M., Fischbein, M. P., Fearon, W. F., Daniels, D., Spies, C., Chhatriwalla, A. K., Suradi, H. S., Shah, P., Szerlip, M., Dahle, T., Apostolou, D., …, & Généreux, P. (2026). Age and Procedural Timing for Asymptomatic Severe Aortic Stenosis: Analysis From the EARLY TAVR Trial. Circulation: Cardiovascular Interventions, 19(8). https://doi.org/10.1161/circinterventions.125.016370

Vancouver

Goel K, Lindman BR, Schwartz A, Cohen DJ, Giustino G, Oldemeyer JB, et al. Age and Procedural Timing for Asymptomatic Severe Aortic Stenosis: Analysis From the EARLY TAVR Trial. Circulation: Cardiovascular Interventions. 2026;19(8). doi:10.1161/circinterventions.125.016370

BibTeX
@article{Goel2026,
  author = {Goel, Kashish and Lindman, Brian R and Schwartz, Allan and Cohen, David J and Giustino, Gennaro and Oldemeyer, J Bradley and Strote, Justin and Babaliaros, Vasilis and Devireddy, Chandan M and Fischbein, Michael P and Fearon, William F and Daniels, David and Spies, Christian and Chhatriwalla, Adnan K and Suradi, Hussam S and Shah, Pinak and Szerlip, Molly and Dahle, Thom and Apostolou, Dimitrios and Makkar, Raj and Davidson, Charles J and Sheth, Tej and Sorajja, Paul and DeVries, James T and Southard, Jeffrey and Depta, Jeremiah P and Pop, Andrei and Rinaldi, Michael J and Badr, Salem and Williams, Mathew R and Russo, Mark J and Guerrero, Mayra and McCabe, James M and Pibarot, Philippe and Wang, Yizhuo and Leon, Martin B and Généreux, Philippe},
  title = {Age and Procedural Timing for Asymptomatic Severe Aortic Stenosis: Analysis From the EARLY TAVR Trial},
  journal = {Circulation: Cardiovascular Interventions},
  year = {2026},
  volume = {19},
  number = {8},
  doi = {10.1161/circinterventions.125.016370}
}
Kostenlos starten →